# Deferoxamine

NDC: 63323-599
Generic name: DEFEROXAMINE MESYLATE
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20091215

FDA application: ANDA078718

## Active ingredients

- DEFEROXAMINE MESYLATE: 95 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-599"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-599
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d91e16df-8daa-4cd2-86a2-273eaa2446e0